Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2021-2027
SKU ID : QYR-17768790 | Publishing Date : 22-Mar-2021 | No. of pages : 108
Detailed TOC of Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CDMO Services Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Substance Development and Manufacturing
1.2.3 Specialized Services
1.2.4 Lab-based Services
1.3 Market by Application
1.3.1 Global Pharmaceutical CDMO Services Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Innovative Medicine
1.3.3 Patented Drug
1.3.4 Patent Expired Drug
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CDMO Services Market Perspective (2016-2027)
2.2 Pharmaceutical CDMO Services Growth Trends by Regions
2.2.1 Pharmaceutical CDMO Services Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmaceutical CDMO Services Historic Market Share by Regions (2016-2021)
2.2.3 Pharmaceutical CDMO Services Forecasted Market Size by Regions (2022-2027)
2.3 Pharmaceutical CDMO Services Industry Dynamic
2.3.1 Pharmaceutical CDMO Services Market Trends
2.3.2 Pharmaceutical CDMO Services Market Drivers
2.3.3 Pharmaceutical CDMO Services Market Challenges
2.3.4 Pharmaceutical CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CDMO Services Players by Revenue
3.1.1 Global Top Pharmaceutical CDMO Services Players by Revenue (2016-2021)
3.1.2 Global Pharmaceutical CDMO Services Revenue Market Share by Players (2016-2021)
3.2 Global Pharmaceutical CDMO Services Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CDMO Services Revenue
3.4 Global Pharmaceutical CDMO Services Market Concentration Ratio
3.4.1 Global Pharmaceutical CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CDMO Services Revenue in 2020
3.5 Pharmaceutical CDMO Services Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CDMO Services Product Solution and Service
3.7 Date of Enter into Pharmaceutical CDMO Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CDMO Services Breakdown Data by Type
4.1 Global Pharmaceutical CDMO Services Historic Market Size by Type (2016-2021)
4.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2022-2027)
5 Pharmaceutical CDMO Services Breakdown Data by Application
5.1 Global Pharmaceutical CDMO Services Historic Market Size by Application (2016-2021)
5.2 Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Pharmaceutical CDMO Services Market Size (2016-2027)
6.2 North America Pharmaceutical CDMO Services Market Size by Type
6.2.1 North America Pharmaceutical CDMO Services Market Size by Type (2016-2021)
6.2.2 North America Pharmaceutical CDMO Services Market Size by Type (2022-2027)
6.2.3 North America Pharmaceutical CDMO Services Market Size by Type (2016-2027)
6.3 North America Pharmaceutical CDMO Services Market Size by Application
6.3.1 North America Pharmaceutical CDMO Services Market Size by Application (2016-2021)
6.3.2 North America Pharmaceutical CDMO Services Market Size by Application (2022-2027)
6.3.3 North America Pharmaceutical CDMO Services Market Size by Application (2016-2027)
6.4 North America Pharmaceutical CDMO Services Market Size by Country
6.4.1 North America Pharmaceutical CDMO Services Market Size by Country (2016-2021)
6.4.2 North America Pharmaceutical CDMO Services Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pharmaceutical CDMO Services Market Size (2016-2027)
7.2 Europe Pharmaceutical CDMO Services Market Size by Type
7.2.1 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2021)
7.2.2 Europe Pharmaceutical CDMO Services Market Size by Type (2022-2027)
7.2.3 Europe Pharmaceutical CDMO Services Market Size by Type (2016-2027)
7.3 Europe Pharmaceutical CDMO Services Market Size by Application
7.3.1 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2021)
7.3.2 Europe Pharmaceutical CDMO Services Market Size by Application (2022-2027)
7.3.3 Europe Pharmaceutical CDMO Services Market Size by Application (2016-2027)
7.4 Europe Pharmaceutical CDMO Services Market Size by Country
7.4.1 Europe Pharmaceutical CDMO Services Market Size by Country (2016-2021)
7.4.2 Europe Pharmaceutical CDMO Services Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CDMO Services Market Size (2016-2027)
8.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type
8.2.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application
8.3.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region
8.4.1 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pharmaceutical CDMO Services Market Size (2016-2027)
9.2 Latin America Pharmaceutical CDMO Services Market Size by Type
9.2.1 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2021)
9.2.2 Latin America Pharmaceutical CDMO Services Market Size by Type (2022-2027)
9.2.3 Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2027)
9.3 Latin America Pharmaceutical CDMO Services Market Size by Application
9.3.1 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2021)
9.3.2 Latin America Pharmaceutical CDMO Services Market Size by Application (2022-2027)
9.3.3 Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2027)
9.4 Latin America Pharmaceutical CDMO Services Market Size by Country
9.4.1 Latin America Pharmaceutical CDMO Services Market Size by Country (2016-2021)
9.4.2 Latin America Pharmaceutical CDMO Services Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CDMO Services Market Size (2016-2027)
10.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type
10.2.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application
10.3.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country
10.4.1 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Recipharm AB
11.1.1 Recipharm AB Company Details
11.1.2 Recipharm AB Business Overview
11.1.3 Recipharm AB Pharmaceutical CDMO Services Introduction
11.1.4 Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.1.5 Recipharm AB Recent Development
11.2 AMRI Global
11.2.1 AMRI Global Company Details
11.2.2 AMRI Global Business Overview
11.2.3 AMRI Global Pharmaceutical CDMO Services Introduction
11.2.4 AMRI Global Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.2.5 AMRI Global Recent Development
11.3 Patheon N.V.
11.3.1 Patheon N.V. Company Details
11.3.2 Patheon N.V. Business Overview
11.3.3 Patheon N.V. Pharmaceutical CDMO Services Introduction
11.3.4 Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.3.5 Patheon N.V. Recent Development
11.4 Aenova Group
11.4.1 Aenova Group Company Details
11.4.2 Aenova Group Business Overview
11.4.3 Aenova Group Pharmaceutical CDMO Services Introduction
11.4.4 Aenova Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.4.5 Aenova Group Recent Development
11.5 Catalent, Inc.
11.5.1 Catalent, Inc. Company Details
11.5.2 Catalent, Inc. Business Overview
11.5.3 Catalent, Inc. Pharmaceutical CDMO Services Introduction
11.5.4 Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.5.5 Catalent, Inc. Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup Pharmaceutical CDMO Services Introduction
11.6.4 Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.6.5 Amatsigroup Recent Development
11.7 WuXi AppTec Group
11.7.1 WuXi AppTec Group Company Details
11.7.2 WuXi AppTec Group Business Overview
11.7.3 WuXi AppTec Group Pharmaceutical CDMO Services Introduction
11.7.4 WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.7.5 WuXi AppTec Group Recent Development
11.8 Strides Pharma Science Limited
11.8.1 Strides Pharma Science Limited Company Details
11.8.2 Strides Pharma Science Limited Business Overview
11.8.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Introduction
11.8.4 Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.8.5 Strides Pharma Science Limited Recent Development
11.9 Piramal Pharma Solutions
11.9.1 Piramal Pharma Solutions Company Details
11.9.2 Piramal Pharma Solutions Business Overview
11.9.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Introduction
11.9.4 Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.9.5 Piramal Pharma Solutions Recent Development
11.10 Siegfried Ltd
11.10.1 Siegfried Ltd Company Details
11.10.2 Siegfried Ltd Business Overview
11.10.3 Siegfried Ltd Pharmaceutical CDMO Services Introduction
11.10.4 Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.10.5 Siegfried Ltd Recent Development
11.11 Fareva Group
11.11.1 Fareva Group Company Details
11.11.2 Fareva Group Business Overview
11.11.3 Fareva Group Pharmaceutical CDMO Services Introduction
11.11.4 Fareva Group Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.11.5 Fareva Group Recent Development
11.12 FAMAR Health Care Services
11.12.1 FAMAR Health Care Services Company Details
11.12.2 FAMAR Health Care Services Business Overview
11.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Introduction
11.12.4 FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2016-2021)
11.12.5 FAMAR Health Care Services Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Pharmaceutical CDMO Services Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Substance Development and Manufacturing
Table 3. Key Players of Specialized Services
Table 4. Key Players of Lab-based Services
Table 5. Global Pharmaceutical CDMO Services Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmaceutical CDMO Services Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pharmaceutical CDMO Services Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pharmaceutical CDMO Services Market Share by Regions (2016-2021)
Table 9. Global Pharmaceutical CDMO Services Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pharmaceutical CDMO Services Market Share by Regions (2022-2027)
Table 11. Pharmaceutical CDMO Services Market Trends
Table 12. Pharmaceutical CDMO Services Market Drivers
Table 13. Pharmaceutical CDMO Services Market Challenges
Table 14. Pharmaceutical CDMO Services Market Restraints
Table 15. Global Pharmaceutical CDMO Services Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pharmaceutical CDMO Services Market Share by Players (2016-2021)
Table 17. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2020)
Table 18. Ranking of Global Top Pharmaceutical CDMO Services Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pharmaceutical CDMO Services Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pharmaceutical CDMO Services Product Solution and Service
Table 22. Date of Enter into Pharmaceutical CDMO Services Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2016-2021)
Table 26. Global Pharmaceutical CDMO Services Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pharmaceutical CDMO Services Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2016-2021)
Table 30. Global Pharmaceutical CDMO Services Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pharmaceutical CDMO Services Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pharmaceutical CDMO Services Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pharmaceutical CDMO Services Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pharmaceutical CDMO Services Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pharmaceutical CDMO Services Market Size by Country (2022-2027) & (US$ Million)
Table 62. Recipharm AB Company Details
Table 63. Recipharm AB Business Overview
Table 64. Recipharm AB Pharmaceutical CDMO Services Product
Table 65. Recipharm AB Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 66. Recipharm AB Recent Development
Table 67. AMRI Global Company Details
Table 68. AMRI Global Business Overview
Table 69. AMRI Global Pharmaceutical CDMO Services Product
Table 70. AMRI Global Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 71. AMRI Global Recent Development
Table 72. Patheon N.V. Company Details
Table 73. Patheon N.V. Business Overview
Table 74. Patheon N.V. Pharmaceutical CDMO Services Product
Table 75. Patheon N.V. Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 76. Patheon N.V. Recent Development
Table 77. Aenova Group Company Details
Table 78. Aenova Group Business Overview
Table 79. Aenova Group Pharmaceutical CDMO Services Product
Table 80. Aenova Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 81. Aenova Group Recent Development
Table 82. Catalent, Inc. Company Details
Table 83. Catalent, Inc. Business Overview
Table 84. Catalent, Inc. Pharmaceutical CDMO Services Product
Table 85. Catalent, Inc. Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 86. Catalent, Inc. Recent Development
Table 87. Amatsigroup Company Details
Table 88. Amatsigroup Business Overview
Table 89. Amatsigroup Pharmaceutical CDMO Services Product
Table 90. Amatsigroup Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 91. Amatsigroup Recent Development
Table 92. WuXi AppTec Group Company Details
Table 93. WuXi AppTec Group Business Overview
Table 94. WuXi AppTec Group Pharmaceutical CDMO Services Product
Table 95. WuXi AppTec Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 96. WuXi AppTec Group Recent Development
Table 97. Strides Pharma Science Limited Company Details
Table 98. Strides Pharma Science Limited Business Overview
Table 99. Strides Pharma Science Limited Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 100. Strides Pharma Science Limited Recent Development
Table 101. Piramal Pharma Solutions Company Details
Table 102. Piramal Pharma Solutions Business Overview
Table 103. Piramal Pharma Solutions Pharmaceutical CDMO Services Product
Table 104. Piramal Pharma Solutions Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 105. Piramal Pharma Solutions Recent Development
Table 106. Siegfried Ltd Company Details
Table 107. Siegfried Ltd Business Overview
Table 108. Siegfried Ltd Pharmaceutical CDMO Services Product
Table 109. Siegfried Ltd Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 110. Siegfried Ltd Recent Development
Table 111. Fareva Group Company Details
Table 112. Fareva Group Business Overview
Table 113. Fareva Group Pharmaceutical CDMO Services Product
Table 114. Fareva Group Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 115. Fareva Group Recent Development
Table 116. FAMAR Health Care Services Company Details
Table 117. FAMAR Health Care Services Business Overview
Table 118. FAMAR Health Care Services Pharmaceutical CDMO Services Product
Table 119. FAMAR Health Care Services Revenue in Pharmaceutical CDMO Services Business (2016-2021) & (US$ Million)
Table 120. FAMAR Health Care Services Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CDMO Services Market Share by Type: 2020 VS 2027
Figure 2. Drug Substance Development and Manufacturing Features
Figure 3. Specialized Services Features
Figure 4. Lab-based Services Features
Figure 5. Global Pharmaceutical CDMO Services Market Share by Application: 2020 VS 2027
Figure 6. Innovative Medicine Case Studies
Figure 7. Patented Drug Case Studies
Figure 8. Patent Expired Drug Case Studies
Figure 9. Pharmaceutical CDMO Services Report Years Considered
Figure 10. Global Pharmaceutical CDMO Services Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pharmaceutical CDMO Services Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pharmaceutical CDMO Services Market Share by Regions: 2020 VS 2027
Figure 13. Global Pharmaceutical CDMO Services Market Share by Regions (2022-2027)
Figure 14. Global Pharmaceutical CDMO Services Market Share by Players in 2020
Figure 15. Global Top Pharmaceutical CDMO Services Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical CDMO Services as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical CDMO Services Revenue in 2020
Figure 17. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2016-2021)
Figure 18. Global Pharmaceutical CDMO Services Revenue Market Share by Type (2022-2027)
Figure 19. North America Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pharmaceutical CDMO Services Market Share by Type (2016-2027)
Figure 21. North America Pharmaceutical CDMO Services Market Share by Application (2016-2027)
Figure 22. North America Pharmaceutical CDMO Services Market Share by Country (2016-2027)
Figure 23. United States Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pharmaceutical CDMO Services Market Share by Type (2016-2027)
Figure 27. Europe Pharmaceutical CDMO Services Market Share by Application (2016-2027)
Figure 28. Europe Pharmaceutical CDMO Services Market Share by Country (2016-2027)
Figure 29. Germany Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pharmaceutical CDMO Services Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pharmaceutical CDMO Services Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pharmaceutical CDMO Services Market Share by Region (2016-2027)
Figure 39. China Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pharmaceutical CDMO Services Market Share by Type (2016-2027)
Figure 47. Latin America Pharmaceutical CDMO Services Market Share by Application (2016-2027)
Figure 48. Latin America Pharmaceutical CDMO Services Market Share by Country (2016-2027)
Figure 49. Mexico Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pharmaceutical CDMO Services Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pharmaceutical CDMO Services Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pharmaceutical CDMO Services Market Share by Country (2016-2027)
Figure 55. Turkey Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pharmaceutical CDMO Services Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Recipharm AB Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 59. AMRI Global Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 60. Patheon N.V. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 61. Aenova Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 62. Catalent, Inc. Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 63. Amatsigroup Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 64. WuXi AppTec Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 65. Strides Pharma Science Limited Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 66. Piramal Pharma Solutions Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 67. Siegfried Ltd Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 68. Fareva Group Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 69. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical CDMO Services Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Keyplayers in Global Pharmaceutical CDMO Services Market Size, Status and Forecast 2021-2027
Recipharm ABAMRI Global
Patheon N.V.
Aenova Group
Catalent, Inc.
Amatsigroup
WuXi AppTec Group
Strides Pharma Science Limited
Piramal Pharma Solutions
Siegfried Ltd
Fareva Group
FAMAR Health Care Services